Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed

Permanent URI for this communityhttps://hdl.handle.net/20.500.14719/1741

Browse

Filters

2021 - 20222

Settings

Start date: 2010Type: search.filters.itemtype.ReviewSubject: search.filters.subject.Genel ve Dahili TıpSubject: search.filters.subject.Sağlık Bilimleri ve HizmetleriAuthor: search.filters.author.Ulu, Memnune Sena

Search Results

Now showing 1 - 2 of 2
  • No Thumbnail Available
    PublicationOpen Access
    Do Hemodialysis Patients Need Immune Boosting with Vitamin, Mineral, and Probiotic Supplementation during COVID-19 Pandemic?
    (2021) Arıcı, Mustafa; Turgut, Didem; Ulu, Memnune Sena; Güngör, Özkan; Onan, Engin; Hasbal, Nuri Barış; Hacettepe Üniversitesi; Başkent Üniversitesi; Bahçeşehir Üniversitesi; Kahramanmaraş Sütçü İmam Üniversitesi; T.C. Sağlık Bakanlığı; T.C. Sağlık Bakanlığı
    Coronavirus disease 2019 (COVID-19) has been accepted as a global pandemic, and poses a greater risk to the elderly and those with comorbidities. Comorbid diseases (particularly end-stage kidney disease with hemodialysis) and impaired immunity place patients in the high-risk group for COVID-19. In recent studies, it was also mentioned that exaggerated inflammation and a cytokine storm were the underlying causes related to the high mortality in COVID-19 patients. Currently, treatment modalities to balance the immune system of such vulnerable patient groups are essential, to protect them from the disease. Several vitamins (like vitamins C, D, and E), trace elements like zinc, and probiotics have been proposed as immune boosters to protect and combat infectious conditions. It is well known that these vitamins and elements are insufficient in hemodialysis patients. In this review, we aimed to evaluate the immune-boosting mechanisms of vitamins C, D, E, zinc, and probiotics, the studies related to their beneficial effects against infections, and their possible benefits for hemodialysis patients during the COVID-19 pandemic.
  • No Thumbnail Available
    PublicationOpen Access
    Sarcopenia in Patients with Chronic Kidney Disease
    (2022) Ulu, Memnune Sena; Güngör, Özkan; Güzel, Fatma Betül; Kalantar-Zadeh, Kamyar; Bahçeşehir Üniversitesi; Kahramanmaraş Sütçü İmam Üniversitesi; Kahramanmaraş Sütçü İmam Üniversitesi; Yabancı Kurumlar
    Sarcopenia is defined as a decrease in muscle mass and muscle strength, and its frequency increases with aging. Since \rdifferent criteria and methods can be used for its definition, its incidence rates vary. Chronic kidney disease is a progressive process and many systems may be affected in these patients. Studies also show that chronic kidney disease can lead \rto the development of sarcopenia. Many factors are held responsible for the development of sarcopenia in chronic kidney \rdisease. Age, inflammation, malnutrition, uremic toxins, and hormonal imbalance are the most important ones. In this \rreview, general information about sarcopenia and the development of sarcopenia in patients with chronic kidney disease \rare discussed in light of the literature.